FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300761490> ?p ?o ?g. }

• W4300761490 endingPage "1231" @default.
• W4300761490 startingPage "1224" @default.
• W4300761490 abstract "Participants were patients with invasive breast cancer undergoing primary surgery. The aim was to test whether a single dose of amoxicillin-clavulanic acid would reduce wound infection at 30 days postoperatively, and to identify risk factors for infection.Participants were randomised to either a single bolus of 1.2 g intravenous amoxicillin-clavulanic acid after the induction of anaesthesia (intervention) or no antibiotic (control). The primary outcome was the incidence of wound infection at 30 days postoperatively.There were 871 evaluable patients. Of these, 438 received prophylactic antibiotic and 433 served as controls. Seventy-one (16.2 per cent) patients in the intervention group developed a wound infection by 30 days, while there were 83 (19.2 per cent) infections in the control group. This was not statistically significant (odds ratio (OR) 0.82, 95 per cent c.i. 0.58 to 1.15; P = 0.250). The risk of infection increased for every 5 kg/m2 of BMI (OR 1.29, 95 per cent c.i. 1.10 to 1.52; P = 0.003). Patients who were preoperative carriers of Staphylococcus aureus had an increased risk of postoperative wound infection; however, there was no benefit of preoperative antibiotics for patients with either a high BMI or who were carriers of S. aureus.There was no statistically significant or clinically meaningful reduction in wound infection at 30 days following breast cancer surgery in patients who received a single dose of amoxicillin-clavulanic acid preoperatively.N0399145605 (National Research Register).There is little research about antibiotics in breast cancer surgery. Surgeons are not certain whether or not to use antibiotics for their patients. The aim of the Prophylactic Antibiotic Use in Surgery (PAUS) trial was to ask a question, ‘Do preoperative antibiotics have any benefit for patients having surgery for breast cancer?’ In the PAUS trial patients were given information to decide whether they wished to take part in the trial or not. Participants were randomly placed in one of two groups. Half were given one dose of the amoxicillin–clavulanic acid antibiotic at the time of their operation. The other half had no antibiotic. Neither the patient nor the surgeon knew which group the patient was in. Patients were carefully checked until 30 days after their operation for signs of wound infection. Altogether, 871 patients agreed to take part in the PAUS trial. Of these, 438 patients had the antibiotic and 433 had no antibiotic. The PAUS trial showed that there was no difference in the number of wound infections when comparing the two groups. Seventy-one patients (16.2 per cent) who had been given the antibiotic developed a wound infection by 30 days versus 83 (19.2 per cent) in the group who had not been given the antibiotic. This trial shows that antibiotics may not be needed for breast cancer surgery. PAUS may help to cut down on unnecessary antibiotic use." @default.
• W4300761490 created "2022-10-04" @default.
• W4300761490 creator A5014442364 @default.
• W4300761490 creator A5014754211 @default.
• W4300761490 creator A5026774549 @default.
• W4300761490 creator A5036659787 @default.
• W4300761490 creator A5055100972 @default.
• W4300761490 creator A5061749118 @default.
• W4300761490 creator A5066402714 @default.
• W4300761490 date "2022-08-06" @default.
• W4300761490 modified "2023-10-06" @default.
• W4300761490 title "Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial" @default.
• W4300761490 cites W1974371563 @default.
• W4300761490 cites W1987785286 @default.
• W4300761490 cites W2005739743 @default.
• W4300761490 cites W2007561235 @default.
• W4300761490 cites W2010608825 @default.
• W4300761490 cites W2021367610 @default.
• W4300761490 cites W2031587110 @default.
• W4300761490 cites W2032541700 @default.
• W4300761490 cites W2050264725 @default.
• W4300761490 cites W2091455084 @default.
• W4300761490 cites W2129658652 @default.
• W4300761490 cites W2131980002 @default.
• W4300761490 cites W2133760158 @default.
• W4300761490 cites W2153600671 @default.
• W4300761490 cites W2159716290 @default.
• W4300761490 cites W2163952503 @default.
• W4300761490 cites W2202325849 @default.
• W4300761490 cites W2319396397 @default.
• W4300761490 cites W2320358601 @default.
• W4300761490 cites W2333849863 @default.
• W4300761490 cites W2413871711 @default.
• W4300761490 cites W2588136715 @default.
• W4300761490 cites W2617705562 @default.
• W4300761490 cites W2794623497 @default.
• W4300761490 cites W2798795107 @default.
• W4300761490 cites W2920195375 @default.
• W4300761490 cites W2988001047 @default.
• W4300761490 cites W3017073206 @default.
• W4300761490 cites W3048466431 @default.
• W4300761490 cites W3062393247 @default.
• W4300761490 cites W3087025410 @default.
• W4300761490 cites W3087246946 @default.
• W4300761490 cites W4233385354 @default.
• W4300761490 cites W4234997272 @default.
• W4300761490 cites W4247903468 @default.
• W4300761490 cites W4251882485 @default.
• W4300761490 doi "https://doi.org/10.1093/bjs/znac280" @default.
• W4300761490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35932230" @default.
• W4300761490 hasPublicationYear "2022" @default.
• W4300761490 type Work @default.
• W4300761490 citedByCount "2" @default.
• W4300761490 countsByYear W43007614902023 @default.
• W4300761490 crossrefType "journal-article" @default.
• W4300761490 hasAuthorship W4300761490A5014442364 @default.
• W4300761490 hasAuthorship W4300761490A5014754211 @default.
• W4300761490 hasAuthorship W4300761490A5026774549 @default.
• W4300761490 hasAuthorship W4300761490A5036659787 @default.
• W4300761490 hasAuthorship W4300761490A5055100972 @default.
• W4300761490 hasAuthorship W4300761490A5061749118 @default.
• W4300761490 hasAuthorship W4300761490A5066402714 @default.
• W4300761490 hasBestOaLocation W43007614901 @default.
• W4300761490 hasConcept C120665830 @default.
• W4300761490 hasConcept C121332964 @default.
• W4300761490 hasConcept C121608353 @default.
• W4300761490 hasConcept C126322002 @default.
• W4300761490 hasConcept C141071460 @default.
• W4300761490 hasConcept C156957248 @default.
• W4300761490 hasConcept C168563851 @default.
• W4300761490 hasConcept C2777704003 @default.
• W4300761490 hasConcept C2778602436 @default.
• W4300761490 hasConcept C2779454058 @default.
• W4300761490 hasConcept C2779708577 @default.
• W4300761490 hasConcept C501593827 @default.
• W4300761490 hasConcept C530470458 @default.
• W4300761490 hasConcept C61511704 @default.
• W4300761490 hasConcept C71924100 @default.
• W4300761490 hasConcept C86803240 @default.
• W4300761490 hasConcept C89423630 @default.
• W4300761490 hasConceptScore W4300761490C120665830 @default.
• W4300761490 hasConceptScore W4300761490C121332964 @default.
• W4300761490 hasConceptScore W4300761490C121608353 @default.
• W4300761490 hasConceptScore W4300761490C126322002 @default.
• W4300761490 hasConceptScore W4300761490C141071460 @default.
• W4300761490 hasConceptScore W4300761490C156957248 @default.
• W4300761490 hasConceptScore W4300761490C168563851 @default.
• W4300761490 hasConceptScore W4300761490C2777704003 @default.
• W4300761490 hasConceptScore W4300761490C2778602436 @default.
• W4300761490 hasConceptScore W4300761490C2779454058 @default.
• W4300761490 hasConceptScore W4300761490C2779708577 @default.
• W4300761490 hasConceptScore W4300761490C501593827 @default.
• W4300761490 hasConceptScore W4300761490C530470458 @default.
• W4300761490 hasConceptScore W4300761490C61511704 @default.
• W4300761490 hasConceptScore W4300761490C71924100 @default.
• W4300761490 hasConceptScore W4300761490C86803240 @default.
• W4300761490 hasConceptScore W4300761490C89423630 @default.
• W4300761490 hasIssue "12" @default.

• next